Delivery Order SPE2DB22D3016-SPE2DB24FBFB3

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,430.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024 and does not have a set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor in the United States, has been awarded numerous federal contracts to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $3,773.64, is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The award has a firm fixed price pricing type and an ultimate completion date of September 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,193.87, is a delivery order for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of July 30, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide the specified...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,741.68 Delivery Order contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The award has a firm fixed price and an ultimate completion date of August 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,757.66 delivery order is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is a firm fixed price, has no set-aside designation, and has an ultimate completion date of July 22, 2024. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by DLA and other...
This federal contract award, valued at $1,552.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of TRULICITY 3 MG/0.5 ML PEN 0.8ML, a diabetes medication. The contract has an ultimate completion date of August 12, 2024 and is a firm fixed-price arrangement. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds several...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery order of TRULICITY 3 MG/0.5 ML PEN 0.5ML, which are pharmaceutical products. The contract has a completion date of July 19, 2024 and is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The fixed-price delivery order, valued at $2,112.18, has a completion date of September 12, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded this contract to supply the specified pharmaceutical product to support federal healthcare programs...
This federal contract award, valued at $7,276.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBFB3
    Delivery Order

This federal contract award, valued at $2,612.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The award has an ultimate completion date of August 27, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to supply a wide range of essential pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide.

Generated 11/25/24, 9:31 AM